HMD

0.00%

2.1¢ heramed limited

and then you see these LinkedIn posts… this polish mob have a...

First 60 Last

Share
Profile

Follow
dunnomuch

2,237 Posts.

913

29/11/23

13:58

Post #: 71169870
Share

Originally posted by Kirpa: ↑

The board really has been asleep at the wheel. One wonders if they should take this unlisted. Dunno, you mentioned the Netherlands and Philips. Ironically, as an Old Minnett client, I last week received a presentation and term sheet for a maximum $15M raise for an unlisted medical AI company called Nicolab who have a strategic partnership with Philips and was founded by two Dutch clinicians in Amsterdam. They have a good chunk of the $15M already corner-stoned at a valuation of $135M. The raise will give them three years runway and they probably never have to list. They are targeting an aggressive expansion over the next few years with Philips in the US and Asia. They also partnered with Titan Neurosciences here in Australia and are the front runner for a $20M Federal Govt grant in 2024. There are lots of grants available in med tech and HMD needs to start getting some big grant wins.

There are significant advantages in being unlisted which leads into the question, would HMD be far better off doing a $10M rights issue (so you can choose to be diluted or not) to give them two years runway and then delisting off the asx? It seems like a lot of damage has been done as a listed ASX company and that damage is not easily reversed. What's the point of small regular raises on the ASX which is just kicking the can down the road? They raise small and then they're cum raise within six months. It's a vicious cycle and the board has a lot to answer for.

Expand

and then you see these LinkedIn posts… this polish mob have a clumsy sort of apparatus but are gaining commercial traction ahead of HMD… there really is a genuine market out there, somehow we just aren’t kicking goals

HMD Price at posting: 4.0¢ Sentiment: None Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 11 more messages in this thread...

First 60 Last

Add HMD (ASX) to my watchlist

(20min delay)
Last 2.1¢		Change 0.000(0.00%)		Mkt cap ! $13.29M

Open	High	Low	Value	Volume
2.1¢	2.1¢	2.1¢	$7.741K	368.6K

Buyers (Bids)

No.	Vol.	Price($)
2	800001	2.0¢

Sellers (Offers)

Price($)	Vol.	No.
2.3¢	200000	1

View Market Depth

No.	Vol.	Price($)
2	800001	0.020
1	998971	0.018
2	1042548	0.015
1	200000	0.014
1	500000	0.013

Price($)	Vol.	No.
0.023	200000	1
0.024	200000	1
0.025	72222	1
0.027	150000	1
0.028	150000	1

Last trade - 13.02pm 04/10/2024 (20 minute delay)

HMD (ASX) Chart

and then you see these LinkedIn posts… this polish mob have a...

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

and then you see these LinkedIn posts… this polish mob have a...

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News